NOMAD POWER SOLUTIONS, INC. Related Party Costs
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Related Party Costs of $2.55 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RelatedPartyCosts · last filed 2023-03-29
- NOMAD POWER SOLUTIONS, INC. related party costs for the quarter ending 2022-12-31 was $584.21K, a 1.87% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. related party costs for the quarter ending 2022-09-30 was $643.96K, a 12.29% increase year-over-year.
- NOMAD POWER SOLUTIONS, INC. related party costs for the quarter ending 2022-06-30 was $753.53K.
- NOMAD POWER SOLUTIONS, INC. related party costs for the quarter ending 2022-03-31 was $565.92K, a 30.65% decline year-over-year.
- NOMAD POWER SOLUTIONS, INC. related party costs for fiscal 2022 was $2.55M, a 15.76% decline from fiscal 2021.
- NOMAD POWER SOLUTIONS, INC. related party costs for fiscal 2021 was $3.02M, a 295.26% increase from fiscal 2020.
- NOMAD POWER SOLUTIONS, INC. related party costs for fiscal 2020 was $765.09K.
| Period end | Related Party Costs 3 month | Related Party Costs 6 month | Related Party Costs 9 month | Related Party Costs 12 month | Related Party Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $584.21K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.23M derived: sum of 2 quarters · filed 2023-03-29 | $1.98M derived: sum of 3 quarters · filed 2023-03-29 | $2.55M 10-K · filed 2023-03-29 | |
| 2022-09-30 | $643.96K 10-Q · filed 2022-11-08 | $1.40M derived: sum of 2 quarters · filed 2023-03-29 | $1.96M 10-Q · filed 2022-11-08 | $2.54M derived: sum of 4 quarters · filed 2023-03-29 | |
| 2022-06-30 | $753.53K derived: 10-K 12 month − 3 quarters · filed 2023-03-29 | $1.32M derived: sum of 2 quarters · filed 2023-03-29 | $1.89M derived: sum of 3 quarters · filed 2023-03-29 | $2.47M derived: sum of 4 quarters · filed 2023-03-29 | |
| 2022-03-31 | $565.92K 10-Q · filed 2022-05-11 | $1.14M derived: sum of 2 quarters · filed 2023-03-29 | $1.71M derived: sum of 3 quarters · filed 2023-03-29 | ||
| 2021-12-31 | $573.47K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.15M derived: sum of 2 quarters · filed 2023-03-29 | $3.02M 10-K · filed 2023-03-29 | $3.02M 10-K · filed 2022-03-21 | |
| 2021-09-30 | $573.47K 10-Q · filed 2022-11-08 | $2.45M 10-Q · filed 2022-11-08 | |||
| 2021-03-31 | $816.03K 10-Q · filed 2022-05-11 | ||||
| 2020-12-31 | $765.09K 10-K · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |